These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1631353)

  • 1. [Hypofibrinolysis in coronary artery disease and predisposing conditions].
    Torrado del Puerto MC; García Frade LJ; García Avello A
    Rev Clin Esp; 1992 Jun; 191(1):1-2. PubMed ID: 1631353
    [No Abstract]   [Full Text] [Related]  

  • 2. Study of serum cholesterol binding reserve in some coronary artery disease risk cases.
    Chandra R; Singh R; Srivastava DK; Gupta AK
    J Assoc Physicians India; 1982 Sep; 30(9):601-4. PubMed ID: 7184925
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood coagulation and fibrinolysis in patients with ischemic heart disease and arterial hypertension or hypotension].
    Shchigel'skiĭ VI; Shchurovkiĭ IuV; Brizinskiĭ MA; Terno VS
    Vrach Delo; 1978 May; (5):40-3. PubMed ID: 676270
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood cadmium level in coronary disease depending on the risk factors].
    Adamska-Dyniewska H; Bała T; Florczak H; Trojanowska B; Trzcinka M
    Kardiol Pol; 1980; 23(6):467-73. PubMed ID: 7420814
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hypercholesterolemia in patients with hypertension and diabetes mellitus. The need for cholesterol control in the prevention of ischemic heart disease].
    Heyden S
    Wien Med Wochenschr; 1986 Sep; 136(17):437-42. PubMed ID: 3798928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical importance of the measurement of lipid abnormalities in diabetes].
    Bourgeois B; Zahnd GR
    Helv Med Acta; 1972 Apr; 36(2):197. PubMed ID: 5029091
    [No Abstract]   [Full Text] [Related]  

  • 7. Fibrinogen and plasminogen activator inhibitor-1 levels in hypertension and coronary heart disease. Potential effects of beta-blockade.
    Teger-Nilsson AC; Larsson PT; Hjemdahl P; Olsson G
    Circulation; 1991 Dec; 84(6 Suppl):VI72-7. PubMed ID: 1683612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of many years of physical exercises on fibrinolysis in patients with arteriosclerosis and hypertension].
    Chumakova VP; Bespalova VG
    Vopr Kurortol Fizioter Lech Fiz Kult; 1977; (2):26-8. PubMed ID: 888377
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fibrinolytic system of the blood in ischemic heart disease associated with arterial hypertension in middle-aged and elderly patients].
    Khamidov NKh; Khamdamova MB
    Klin Med (Mosk); 1987 Jan; 65(1):74-6. PubMed ID: 3560833
    [No Abstract]   [Full Text] [Related]  

  • 10. [Circulating blood platelet aggregates in various diseases].
    Donner L; Setková O; Tomásková K
    Vnitr Lek; 1983 Apr; 29(4):313-9. PubMed ID: 6868406
    [No Abstract]   [Full Text] [Related]  

  • 11. [Serum lipid disturbances, obesity and diabetes among 40-year-old inhabitants of the city and the province of Poznan with arterial hypertension and coronary heart disease in the context of the negative elements of health behaviour].
    Kara I
    Przegl Lek; 2005; 62 Suppl 3():51-4. PubMed ID: 16521920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemostatic factors and inhibitors and coronary artery bypass grafting: preoperative alterations and relations to graft occlusion.
    Moor E; Hamsten A; Blombäck M; Herzfeld I; Wiman B; Rydén L
    Thromb Haemost; 1994 Sep; 72(3):335-42. PubMed ID: 7531874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Physiological and pharmacological aspects of fibrinolysis].
    Fearnley GR
    Clin Ter; 1971 May; 57(3):205-25. PubMed ID: 5110942
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes of certain indicators of blood coagulation in patients with coronary arteriosclerosis and hypertensive disease].
    Pliutto AM
    Lab Delo; 1974; 8(0):465-8. PubMed ID: 4139365
    [No Abstract]   [Full Text] [Related]  

  • 15. Study of plasma hormones and lipids in healthy elderly Thais compared to patients with chronic diseases: diabetes mellitus, essential hypertension and coronary heart disease.
    Chearskul S; Charoenlarp K; Thongtang V; Nitiyanant W
    J Med Assoc Thai; 2000 Mar; 83(3):266-77. PubMed ID: 10808681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemobiology, vascular disease, and diabetes with special reference to impaired fibrinolysis.
    Vague P; Raccah D; Juhan-Vague I
    Metabolism; 1992 May; 41(5 Suppl 1):2-6. PubMed ID: 1574009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary artery disease and fibrinolysis: from the blood to the vessel wall.
    Sobel BE
    Thromb Haemost; 1999 Sep; 82 Suppl 1():8-13. PubMed ID: 10695478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blood lipid disorders and their significance].
    Forster G
    Praxis; 1968 Sep; 57(36):1219. PubMed ID: 5696028
    [No Abstract]   [Full Text] [Related]  

  • 19. Platelet factor 4 levels in patients with coronary artery disease.
    White GL; Marouf AA
    J Lab Clin Med; 1981 Mar; 97(3):369-78. PubMed ID: 6970238
    [No Abstract]   [Full Text] [Related]  

  • 20. Diabetes, but not the metabolic syndrome, predicts the severity and extent of coronary artery disease in women.
    Zornitzki T; Ayzenberg O; Gandelman G; Vered S; Yaskil E; Faraggi D; Caspi A; Goland S; Shvez O; Schattner A; Knobler H
    QJM; 2007 Sep; 100(9):575-81. PubMed ID: 17693419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.